Lantern Pharma gets FDA nod for Harmonic phase 2 clinical trial of LP-300
Lantern Pharma said that the US Food and Drug Administration (FDA) has authorized it to move ahead with its Harmonic phase 2 clinical trial of ... Read More
Merck signs $290m deal with Orion Corporation for mCRPC candidate ODM-208
Merck has signed a global development and commercialization deal worth $290 million with Orion Corporation for the latter’s investigational candidate ODM-208 and other drugs that ... Read More
Amryt gets FDA orphan drug designation for Mycapssa for carcinoid syndrome
Amryt, a commercial-stage biopharma company, has secured orphan drug designation for Mycapssa (octreotide capsules) from the US Food and Drug Administration (FDA) for the treatment ... Read More
Agthia Group to acquire 60% stake in Egyptian snacking firm Auf Group
Agthia Group, an Abu Dhabi-based food and beverage company, revealed plans to acquire a stake of 60% in Auf Group, an Egyptian specialized healthy snacks ... Read More
Adani Ports, Gadot bag Port of Haifa privatization tender in Israel
India-based Adani Ports and Special Economic Zone (APSEZ) in consortium with Israeli chemical company Gadot Group has bagged the Port of Haifa privatization tender in ... Read More
Rex to acquire Australian fly-in fly-out operator National Jet Express
Australian airline Rex has agreed to acquire National Jet Express, the regional services unit of Cobham Aviation Services Australia, for a price of around AUD ... Read More
Prescient Therapeutics gets FDA orphan drug status for PTX-100 in PTCL
Prescient Therapeutics has secured the orphan drug designation for its PTX-100 compound from the US Food and Drug Administration (FDA) for the treatment of peripheral ... Read More
Pepsi Bottling Ventures to install new $35m bottling line in Winston-Salem
Pepsi Bottling Ventures (PBV) will invest $35 million in installing a new bottling line at its production facility in Winston-Salem, North Carolina. Construction of the ... Read More
Sweden’s Essity to acquire 80% stake in leakproof apparel firm Knix Wear
Essity, a Swedish hygiene and health company, has agreed to acquire an 80% stake in Knix Wear, a Canada-based provider of leakproof apparel for periods ... Read More
Glenmark Pharmaceuticals launches MINYM gel for acne treatment
Glenmark Pharmaceuticals has launched a topical Minocycline 4% Gel under the brand name MINYM in India for the treatment of moderate to severe acne. According ... Read More